TYK2 is part of the JAK-STAT signaling pathway that mediates the expression of several drivers of psoriasis, such as Type I IFNs, IL-12, and IL-23, making TYK2 an integral part of inflammation and immune response regulation. Here, SOAT1 is linked to psoriasis.